Cargando…
The Utility of Proton Beam Therapy with Concurrent Chemotherapy for the Treatment of Esophageal Cancers
The standard of care for the management of locally advanced esophageal cancers in the United States is chemotherapy combined with radiation, either definitively, or for those who could tolerate surgery, preoperatively before esophagectomy. Although the appropriate radiation dose remains somewhat con...
Autor principal: | Lin, Steven H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763411/ https://www.ncbi.nlm.nih.gov/pubmed/24213126 http://dx.doi.org/10.3390/cancers3044090 |
Ejemplares similares
-
Proton Beam Therapy for Esophageal Cancer
por: Solidum, Jea Giezl N., et al.
Publicado: (2022) -
Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival Outcomes
por: Rutenberg, Michael S., et al.
Publicado: (2022) -
Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma: a single institutional experience
por: Prayongrat, Anussara, et al.
Publicado: (2017) -
Proton beam therapy with concurrent chemotherapy is feasible in children with newly diagnosed rhabdomyosarcoma
por: Suzuki, Ryoko, et al.
Publicado: (2021) -
Proton beam therapy: clinical utility and current status in prostate cancer
por: Yamoah, Kosj, et al.
Publicado: (2016)